Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.47 |
| ▸ | SLC25A20 | O43772 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.43 |
| ▸ | FDPS | P14324 | 3/20 | 0.43 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31485403 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR | |
| SCHEMBL4638950 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR | |
| SCHEMBL905579 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR | |
| SCHEMBL418811 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR | |
| SCHEMBL60425 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR | |
| SCHEMBL60847 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR | |
| SCHEMBL2695073 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR | |
| SCHEMBL632448 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR | |
| SCHEMBL2693658 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR | |
| SCHEMBL52689 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 242 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9513253-B2 | Droplet actuators and techniques for droplet-based enzymatic assays | ADVANCED LIQUID LOGIC, INC. (US) | 2016-12-06 | — | — | US | claimed |
| US-20140246319-A1 | DROPLET ACTUATORS AND TECHNIQUES FOR DROPLET-BASED ASSAYS | ADVANCED LIQUID LOGIC, INC. (US) | 2014-09-04 | — | — | US | claimed |
| WO-2013009927-A2 | DROPLET ACTUATORS AND TECHNIQUES FOR DROPLET-BASED ASSAYS | ADVANCED LIQUID LOGIC, INC. (US) | 2013-01-17 | — | — | WO | claimed |
| WO-2005007895-A1 | METHODS AND KITS FOR OBTAINING NUCLEIC ACID FROM BIOLOGICAL SAMPLES | APPLERA CORPORATION (US) | 2005-01-27 | — | — | WO | claimed |
| US-20050009036-A1 | Methods and kits for obtaining nucleic acid from biological samples | APPLERA CORPORATION (US) | 2005-01-13 | — | — | US | claimed |
| US-12577543-B2 | Method for producing polyisoprenoid by reaction catalyzed by mutant cis-prenyltransferase (CPT) family protein, and method for producing rubber product | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2026-03-17 | — | — | US | disclosed |
| US-20260002179-A1 | METHOD FOR PRODUCING POLYISOPRENOID, VECTOR, TRANSFORMED PLANT, METHOD FOR PRODUCING PNEUMATIC TIRE, AND METHOD FOR PRODUCING RUBBER PRODUCT | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2026-01-01 | — | — | US | disclosed |
| US-20250326814-A1 | MODIFIED OXYNTOMODULIN AND METHODS OF USE THEREOF | OPKO BIOLOGICS LTD. (IL) | 2025-10-23 | — | — | US | disclosed |
| US-12391964-B2 | Method for producing polyisoprenoid, vector, transformed plant, method for producing pneumatic tire, and method for producing rubber product | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2025-08-19 | — | — | US | disclosed |
| EP-1817048-B2 | STABLE FORMULATIONS OF INSULINOPTROPIC PEPTIDES | NOVO NORDISK AS (DK) | 2025-06-18 | — | — | EP | disclosed |
| EP-3586142-B1 | DETECTION OF MEMBRANE PROTEINS | UNIV OXFORD INNOVATION LTD (GB) | 2024-12-25 | — | — | EP | disclosed |
| US-12146146-B2 | Method for producing trans-polyisoprenoid, vector, transgenic plant, method for producing pneumatic tire and method for producing rubber product | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2024-11-19 | — | — | US | disclosed |
| WO-2004104228-A1 | MICROFLUIDIC PROTEIN CRYSTALLOGRAPHY | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2004-12-02 | — | — | WO | disclosed |
| WO-2004094020-A2 | CRYSTAL GROWTH DEVICES AND SYSTEMS, AND METHODS FOR USING SAME | FLUIDIGM CORPORATION (US) | 2004-11-04 | — | — | WO | disclosed |
| EP-1392484-A4 | HIGH THROUGHPUT SCREENING OF CRYSTALIZATION OF MATERIALS | CALIFORNIA INST OF TECHN (US) | 2004-07-28 | — | — | EP | disclosed |
| US-20040115731-A1 | Microfluidic protein crystallography | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2004-06-17 | — | — | US | disclosed |
| WO-2004038363-A2 | MICROFLUIDIC DEVICE AND METHOD FOR PRESSURE-DRIVEN PLUG TRANSPORT AND REACTION | THE UNIVERSITY OF CHICAGO (US) | 2004-05-06 | — | — | WO | disclosed |
| EP-1392484-A2 | HIGH THROUGHPUT SCREENING OF CRYSTALIZATION OF MATERIALS | California Institute of Technology (US) | 2004-03-03 | — | — | EP | disclosed |
| US-20030061687-A1 | High throughput screening of crystallization materials | CALIFORNIA INSTITUTE OF TECHNOLOGY, A CALIFORNIA CORPORATION | 2003-04-03 | — | — | US | disclosed |
| WO-2002082047-A2 | HIGH THROUGHPUT SCREENING OF CRYSTALLIZATION OF MATERIALS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2002-10-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260002179-A1 | METHOD FOR PRODUCING POLYISOPRENOID, VECTOR, TRANSFORMED PLANT, METHOD FOR PRODUCING PNEUMATIC TIRE, AND METHOD FOR PRODUCING RUBBER PRODUCT | FNTB, FNTA, TPT1 | SMPD1 3050/4885SLC25A20 1827/4885TP53 4013/4885 |
| US-20250326814-A1 | MODIFIED OXYNTOMODULIN AND METHODS OF USE THEREOF | OGFRL1, OXGR1, THOP1 | SMPD1 3534/4885SLC25A20 371/4885TP53 4698/4885 |
| US-12577543-B2 | Method for producing polyisoprenoid by reaction catalyzed by mutant cis-prenyltransferase (CPT) family protein, and method for producing rubber product | FNTB, RTCB, PTAR1 | SMPD1 3516/4885SLC25A20 2458/4885TP53 3876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.